Dermata Therapeutics Inc (DRMA)
1.120
-0.07
(-5.79%)
USD |
NASDAQ |
Nov 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Dermata Therapeutics Enterprise Value: -3.473M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | -3.473M |
| November 14, 2024 | -3.382M |
| November 13, 2024 | -3.328M |
| November 12, 2024 | -3.250M |
| November 11, 2024 | -3.170M |
| November 08, 2024 | -3.124M |
| November 07, 2024 | -3.184M |
| November 06, 2024 | -3.170M |
| November 05, 2024 | -3.250M |
| November 04, 2024 | -3.344M |
| November 01, 2024 | -3.335M |
| October 31, 2024 | -3.276M |
| October 30, 2024 | -3.170M |
| October 29, 2024 | -3.118M |
| October 28, 2024 | -3.026M |
| October 25, 2024 | -2.986M |
| October 24, 2024 | -3.131M |
| October 23, 2024 | -3.039M |
| October 22, 2024 | -2.881M |
| October 21, 2024 | -2.894M |
| October 18, 2024 | -2.828M |
| October 17, 2024 | -2.868M |
| October 16, 2024 | -3.197M |
| October 15, 2024 | -3.250M |
| October 14, 2024 | -3.250M |
| Date | Value |
|---|---|
| October 11, 2024 | -3.170M |
| October 10, 2024 | -3.184M |
| October 09, 2024 | -3.157M |
| October 08, 2024 | -3.144M |
| October 07, 2024 | -3.203M |
| October 04, 2024 | -3.078M |
| October 03, 2024 | -3.065M |
| October 02, 2024 | -2.986M |
| October 01, 2024 | -2.934M |
| September 30, 2024 | -2.789M |
| September 27, 2024 | -2.894M |
| September 26, 2024 | -2.907M |
| September 25, 2024 | -2.907M |
| September 24, 2024 | -2.973M |
| September 23, 2024 | -2.815M |
| September 20, 2024 | -2.605M |
| September 19, 2024 | -2.644M |
| September 18, 2024 | -1.986M |
| September 17, 2024 | -2.236M |
| September 16, 2024 | -1.894M |
| September 13, 2024 | -2.868M |
| September 12, 2024 | -3.039M |
| September 11, 2024 | -2.881M |
| September 10, 2024 | -2.828M |
| September 09, 2024 | -2.802M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.044M
Minimum
Apr 06 2023
48.06M
Maximum
Aug 31 2021
0.5162M
Average
-3.026M
Median
Oct 28 2024
Enterprise Value Benchmarks
| NeuroBo Pharmaceuticals Inc | -2.542M |
| Cognition Therapeutics Inc | -9.839M |
| ZyVersa Therapeutics Inc | 0.9921M |
| Bone Biologics Corp | -0.1884M |
| NovaBay Pharmaceuticals Inc | 2.764M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.829M |
| Total Expenses (Quarterly) | 2.884M |
| EPS Diluted (Quarterly) | -4.18 |
| Earnings Yield | -2.45K% |